How effective is imiquimod treatment for basal cell carcinoma?

Imiquimod is a cream that encourages an immune reaction in treated skin. It is generally considered for superficial lesions rather than every type of basal cell carcinoma. A clinician may assess the biopsy result, depth, borders, size, and body site before recommending it. Redness, crusting, soreness, or irritation during treatment can reflect the intended local response, but severe inflammation may require medical advice. A clear-looking surface does not by itself prove that all abnormal cells have gone, so follow-up matters.

Use the cream exactly on the schedule prescribed and apply it only to the area directed. Wash your hands before and after application, avoid covering the site unless instructed, and protect irritated skin from unnecessary sun exposure. Do not add other creams to the lesion without checking first. Keep every review appointment so the clinician can examine healing and decide whether further treatment or a different approach is needed. More information is available in [Imiquimod Treatment](/treatments/medical-dermatology/imiquimod-therapy/) and [Basal Cell Carcinoma](/conditions/basal-cell-carcinoma/).

Seek prompt advice if pain, swelling, bleeding, discharge, or skin breakdown is worsening, or if irritation prevents normal daily activities. Contact the treating team if you miss applications, accidentally use the cream on nearby mucosa or eyes, or cannot tell where to apply it. A lesion that persists, grows, or changes after the planned course needs reassessment rather than repeated self-treatment.

Ask whether your biopsy describes a superficial lesion, why imiquimod fits its site, how long the course will last, what reaction is expected, and how healing will be checked. You can also ask what alternatives are available if the lesion does not clear.